Get the Stockscreener App
2.31
4.05%
0.09
After Hours:
2.31
Neurobo Pharmaceuticals Inc Stock (NRBO) Forecast
The Neurobo Pharmaceuticals Inc (NRBO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.71, representing a +406.79% increase from the current price of $2.31. The highest analyst price target is $11.39, and the lowest is $12.02.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NRBO Price Target
Average 446.18
(+19,215% Upside)
Is Neurobo Pharmaceuticals Inc (NRBO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.47 | Neutral |
| STOCH(9,6) | 20.99 | Neutral |
| STOCHRSI(14) | 24.30 | Neutral |
| MACD(12,26) | -0.1455 | Sell |
| ADX(14) | 10.62 | Neutral |
| William %R | -83.91 | Buy |
| CCI(14) | -161.95 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.547
Sell
|
2.4948
Sell
|
| MA20 |
2.6445
Sell
|
2.6099
Sell
|
| MA50 |
2.9036
Sell
|
2.8953
Sell
|
| MA100 |
3.4759
Sell
|
3.2124
Sell
|
| MA200 |
3.8863
Sell
|
3.0927
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NRBO could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NRBO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.47 indicates that NRBO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.99 indicates that NRBO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.3 indicates that NRBO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.62 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -161.95 indicates that NRBO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NRBO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neurobo Pharmaceuticals Inc financial reports and earnings history, Neurobo Pharmaceuticals Inc (NRBO) stock could reach $20.23 by 2030, $21.61 by 2040 and $34.75 by 2050. See the projected annual prices until 2050 of the Neurobo Pharmaceuticals Inc stock below:
- Neurobo Pharmaceuticals Inc (NRBO) is expected to reach an average price of $9.5946 in 2035, with a high prediction of $10.12 and a low estimate of $9.6046. This indicates an $315.35% rise from the last recorded price of $2.31.
- Neurobo Pharmaceuticals Inc (NRBO) stock is projected to chart a bullish course in 2040, with an average price target of $21.13, representing an $814.70% surge from its current level. The forecast ranges from a conservative $21.15 to a sky-high $21.61.
- Our analysts predict Neurobo Pharmaceuticals Inc (NRBO) to jump 1,032% by 2045, soaring from $25.10 to an average price of $26.15, potentially reaching $25.32. While $25.10 is the low estimate, the potential upside is significant.
- Neurobo Pharmaceuticals Inc (NRBO) stock is expected to climb by 2050, reaching an average of $32.86, a $1,323% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.75 and $35.95, respectively, highlighting the market's uncertainty.
Neurobo Pharmaceuticals Inc Stock (NRBO) Year by Year Forecast
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2024
Our forecast for NRBO stock price in 2024 now indicates an average price target of $7.5205 with a high forecast of $14.12 and a low forecast of $0.924. The average prediction reflects an increase of +225.56% from the last recorded price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $12.99 | $12.02 | $11.39 | +462.42% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2025
Neurobo Pharmaceuticals Inc Stock (NRBO) is expected to reach an average price of $446.61 in 2025, with a high prediction of $880.33 and a low estimate of $12.88. This indicates an +19,234% rise from the last recorded price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $204.94 | $12.88 | $322.77 | +8,772% |
| February, 2025 | $253.20 | $198.51 | $315.70 | +10,861% |
| March, 2025 | $442.47 | $250.27 | $880.33 | +19,054% |
| April, 2025 | $397.80 | $200.56 | $474.93 | +17,121% |
| May, 2025 | $428.96 | $325.86 | $872.23 | +18,470% |
| June, 2025 | $386.62 | $355.57 | $437.73 | +16,637% |
| July, 2025 | $262.75 | $259.15 | $414.42 | +11,275% |
| August, 2025 | $220.12 | $207.52 | $286.22 | +9,429% |
| September, 2025 | $181.08 | $162.72 | $253.25 | +7,739% |
| October, 2025 | $165.81 | $151.11 | $199.75 | +7,078% |
| November, 2025 | $151.38 | $140.51 | $182.14 | +6,453% |
| December, 2025 | $133.71 | $133.71 | $187.72 | +5,688% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2026
The predicted value for Neurobo Pharmaceuticals Inc (NRBO) in 2026 is set at an average of $139.40. Estimates vary from a peak of $212.11 to a trough of $66.69, indicating an +5,935% surge from the present price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $145.97 | $127.77 | $160.93 | +6,219% |
| February, 2026 | $166.63 | $142.44 | $176.23 | +7,114% |
| March, 2026 | $164.80 | $136.83 | $212.11 | +7,034% |
| April, 2026 | $145.93 | $129.76 | $178.43 | +6,217% |
| May, 2026 | $127.29 | $93.26 | $146.29 | +5,411% |
| June, 2026 | $102.36 | $100.86 | $133.66 | +4,331% |
| July, 2026 | $71.49 | $66.69 | $102.72 | +2,995% |
| August, 2026 | $78.65 | $66.82 | $95.75 | +3,305% |
| September, 2026 | $77.48 | $71.18 | $182.52 | +3,254% |
| October, 2026 | $96.94 | $66.75 | $154.71 | +4,097% |
| November, 2026 | $110.41 | $81.18 | $115.61 | +4,680% |
| December, 2026 | $98.14 | $94.84 | $134.77 | +4,148% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neurobo Pharmaceuticals Inc (NRBO) is $39.86, with a high forecast of $79.60 and a low forecast of $0.1052. This indicates an +1,625% increase from the last price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $42.30 | $41.34 | $79.60 | +1,731% |
| February, 2027 | $34.77 | $33.57 | $49.33 | +1,405% |
| March, 2027 | $30.00 | $26.63 | $42.40 | +1,199% |
| April, 2027 | $26.96 | $23.53 | $40.99 | +1,067% |
| May, 2027 | $16.94 | $12.08 | $27.33 | +633.51% |
| June, 2027 | $11.36 | $8.223 | $17.46 | +391.56% |
| July, 2027 | $15.58 | $9.3211 | $19.05 | +574.55% |
| August, 2027 | $12.56 | $11.59 | $17.21 | +443.84% |
| September, 2027 | $2.0491 | $0.6271 | $13.67 | -11.29% |
| October, 2027 | $2.0552 | $0.5732 | $5.1932 | -11.03% |
| November, 2027 | $6.2312 | $1.9682 | $7.1942 | +169.75% |
| December, 2027 | $1.9442 | $0.1052 | $9.4022 | -15.83% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2028
In 2028, Neurobo Pharmaceuticals Inc (NRBO) is projected to reach an average price of $27.44, with a high projection of $54.22 and a low estimate of $0.6598. This indicates an +1,088% rise from the last price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5907 | $0.9032 | $2.9042 | -74.43% |
| February, 2028 | $4.1893 | $1.1673 | $54.22 | +81.35% |
| March, 2028 | $1.4907 | $0.6598 | $5.1313 | -35.47% |
| April, 2028 | $7.3767 | $6.6797 | $7.4327 | +219.34% |
| May, 2028 | $7.7634 | $7.1926 | $7.2207 | +236.08% |
| June, 2028 | $7.4976 | $7.6226 | $7.6309 | +224.57% |
| July, 2028 | $7.3231 | $7.3457 | $7.3706 | +217.02% |
| August, 2028 | $6.9952 | $7.0085 | $7.2399 | +202.82% |
| September, 2028 | $6.7495 | $6.7685 | $6.8865 | +192.19% |
| October, 2028 | $6.6085 | $6.6175 | $6.64 | +186.08% |
| November, 2028 | $6.3179 | $6.3179 | $6.4945 | +173.50% |
| December, 2028 | $6.1593 | $6.2353 | $6.2698 | +166.64% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2029
The 2029 price forecast for Neurobo Pharmaceuticals Inc Stock (NRBO) is $5.7071 on average, with a high prediction of $11.39 and a low estimate of $0.0241. This represents an +147.06% increase from the previous price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.7534 | $5.7664 | $6.0704 | +149.07% |
| February, 2029 | $5.4922 | $5.5024 | $5.6504 | +137.76% |
| March, 2029 | $5.1987 | $5.3284 | $5.4043 | +125.05% |
| April, 2029 | $4.9974 | $5.0443 | $5.1323 | +116.34% |
| May, 2029 | $4.7142 | $4.7343 | $4.9233 | +104.08% |
| June, 2029 | $4.4304 | $4.4467 | $4.6183 | +91.79% |
| July, 2029 | $0.9196 | $1.4662 | $4.2783 | -60.19% |
| August, 2029 | $1.0162 | $0.8302 | $0.9222 | -56.01% |
| September, 2029 | $1.2778 | $0.0258 | $2.1998 | -44.68% |
| October, 2029 | $0.7678 | $0.4178 | $2.9257 | -66.76% |
| November, 2029 | $0.0581 | $0.0241 | $0.9739 | -97.48% |
| December, 2029 | $18.89 | $0.1199 | $11.39 | +717.75% |
Neurobo Pharmaceuticals Inc Stock (NRBO) Price Forecast for 2030
Neurobo Pharmaceuticals Inc Stock (NRBO) is expected to reach an average price of $440.09 in 2030, with a high forecast of $860.67 and a low forecast of $19.51. This signifies an +18,951% surge from the last price of $2.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.25 | $19.51 | $20.23 | +863.42% |
| February, 2030 | $25.95 | $23.10 | $23.95 | +1,023% |
| March, 2030 | $28.17 | $26.19 | $26.05 | +1,120% |
| April, 2030 | $29.40 | $29.04 | $28.15 | +1,173% |
| May, 2030 | $32.69 | $30.46 | $32.09 | +1,315% |
| June, 2030 | $32.51 | $32.88 | $32.75 | +1,307% |
| July, 2030 | $31.57 | $32.55 | $32.08 | +1,267% |
| August, 2030 | $33.02 | $32.54 | $32.65 | +1,329% |
| September, 2030 | $237.81 | $33.01 | $302.64 | +10,195% |
| October, 2030 | $673.77 | $178.58 | $860.67 | +29,067% |
| November, 2030 | $245.00 | $201.20 | $682.90 | +10,506% |
| December, 2030 | $435.72 | $181.23 | $448.92 | +18,763% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):